Dominant role of the C-terminal domain in the binding of apolipoprotein(a) to the protein core of proteoglycans and other members of the vascular matrix

Trends in Cardiovascular Medicine

Volumn 9, Issue 7, 1999, Pages 196-200

  Scanu, Angelo M ^a   Edelstein, Celina ^a   Klezovitch, Olga ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0343090885     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(00)00020-7     Document Type: Review

References (37)

1. Armstrong VW, Cremer P, Eberle E, et al.: 1986. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis 62:249-257.
2. Baggio G, Donazzan S, Monti D, et al.: 1998. Lipoprotein(a) and lipoprotein profile in healthy centenarians: A reappraisal of vascular risk factors. FASEB J 12.
3. Beisiegal U: 1991. Lipoprotein(a) in the arterial wall. Curr Opin Lipidol 2:317-323.
4. Berg K: 1994. Confounding results of Lp(a) lipoprotein measurements with some test kits. Clin Genet 46:57-62.
5. Bihari-Varga M, Gruber E, Rothenden M, et al.: 1988. Interaction of lipoprotein(a) and low density lipoprotein with glycosaminoglycans from human aorta. Arteriosclerosis 8:851-857.
6. Camejo G, Camejo-Hurt E, Wiklund O, et al.: 1998. Association of apo B lipoproteins with arterial proteoglycans: Pathological significance and molecular basis. Atherosclerosis 139:205-222.
7. Edelstein C, Italia JA, Klezovitch O, et al.: 1996. Functional and metabolic differences between elastase-generated fragments of human lipoprotein(a) and apolipoprotein(a). J Lipid Res 37:1786-1801.
8. Edelstein C, Italia JI, Scanu AM: 1997. Polymorphonuclear cells isolated from human peripheral blood cleave lipoprotein(a) and apolipoprotein(a) at multiple interkringle sites via the enzyme elastase: Generation of mini-Lp(a) particles and apo(a) fragments. J Biol Chem 272:11,079-11,087.
9. Edelstein C, Mandala M, Pfaffinger D, et al.: 1995. Determinants of lipoprotein(a) assembly: A study of wild-type and mutant apolipoprotein(a) phenotypes isolated from human and rhesus monkey lipoprotein(a) under mild reductive conditions. Biochemistry 34:16,483-16,492.
10. Edelstein C, Shapiro SD, Klezovitch O, et al.: 1999. Macrophage metalloelastase, MMP-12, cleaves human apolipoprotein(a) in the linker region between kringles IV-4 and IV-5. Potential relevance to lipoprotein(a) biology. J Biol Chem 274:10,019-10,023.
11. Fless CM, Snyder ML, Scanu AM: 1989. Enzyme-linked immunoassay for Lp(a). J Lipid Res 30:651-662.
12. Fortunate JE, Bassiouny HS, Song RH, et al.: 2000. Apolipoprotein(a) fragments in relation to human carotid plaque instability. J Vasc Surg. In press.
13. Frank S, Durovic S, Kostner GM: 1994. Structural requirements of apo-a for the lipoprotein-a assembly. Biochem J 304:27-30.
14. Galis ZS, Sukhova GK, Lark MW, et al.: 1994. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-2503.
15. Cries A, Nimpf J, Nimpf M, et al.: 1987. Free and apoB-associated Lp(a)-specific protein in human serum. Clin Chim Acta 164:93-100.
16. Herrmann W, Quast S, Wolter K, et al.: 1999. Determination of free apolipoprotein(a) in serum by immunoassay and its significance for risk assessment in patients with coronary artery disease. Clin Chem Lab Med 37:21-28.
17. Hoff HF, Oneil J, Yashiro A: 1993. Partial characterization of lipoproteins containing apo[a] in human atherosclerotic lesions. J Lipid Res 34:789-798.
18. Hopkins PN, Wu LL, Hunt SC, et al.: 1997. Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease. Arterioscler Thromb Vasc Biol 17:2783-2792.
19. Klezovitch O, Edelstein C, Scanu AM: 1996. Evidence that the fibrinogen binding domain of apo(a) is outside the lysine binding site (LBS) of kringle IV-10. A study involving naturally-occurring lysine binding defective lipoprotein(a) phenotypes. J Clin Invest 98:185-191.
20. Klezovitch O, Edelstein C, Zhu L, et al.: 1998. Apolipoprotein(a) binds via its C-terminal domain to the protein core of the proteoglycan decorin. Implications for the retention of lipoprotein(a) in atherosclerotic lesions. J Biol Chem 273:23,856-23,865.
21. Kresse H, Hausser H, Schonherr E, et al.: 1994. Biosynthesis and interactions of small chondroitin/dermatan sulphate proteoglycans. Eur J Clin Chem Clin Biochem 32:259-264.
22. Lawn RM, Wade DP, Hammer RE, et al.: 1992. Atherogenesis in transgenic mice expressing human apolipoprotein(a). Nature 360:670-672.
23. Lundstam U, Camejo-Hurt E, Olsson G, et al.: 1999. Proteoglycans contribution to association of Lp(a) and LDL with smooth muscle cell extracellular matrix. Arterioscler Thromb Vasc Biol 19:1162-1167.
24. McLean JW, Tomlinson JE, Kuang W, et al.: 1987. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330:132-137.
25. Mooser V, Seabra MC, Abedin M, et al.: 1996. Apolipoprotein(a) kringle4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a). J Clin Invest 97:858-864.
26. Ogorelkova M, Gruber A, Utermann G: 1999. Molecular basis of congenital Lp(a) deficiency: A frequent apo(a) "null" mutation in Caucasians. Hum Mol Genet 8:2087-2096.
27. Paananen K, Saarinen J, Annila A, et al.: 1995. Proteolysis and fusion of low density lipoprotein particles strengthen their binding to human aortic proteoglycans. J Biol Chem 270:12,257-12,262.
28. Rader DJ, Cain W, Ikewaki K, et al.: 1994. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in lp(a) catabolism but to differences in production rate. J Clin Invest 93:2758-2763.
29. Scanu AM: 1998. Atherothrombogenicity of lipoprotein(a): The debate. Am J Cardiol 82:26Q-33Q.
30. Scanu AM, Edelstein C: 1995. Kringle-dependent structural and functional polymorphism of apolipoprotein. Biochim Biophys Acta 1256:1-12.
31. Scanu AM, Edelstein C: 1997. Learning about the structure and biology of human lipoprotein(a) through dissection by enzymes of the elastase family: Facts and speculations. J Lipid Res 38:2193-2206.
32. Tabas I: 1999. Nonoxidative modifications of lipoproteins in atherogenesis. Annu Rev Nutr 19:123-139.
33. Thillet J, Doucet C, Chapman J, et al.: 1997. Elevated lipoprotein(a) levels and small apo(A) isoforms are compatible with longevity evidence from a large population of French centenarians. Atherosclerosis 136:389-394.
34. Utermann G: 1995. Lipoprotein(a). In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease. New York, McGraw Hill, Inc., p: 1887.
35. van der Hoek YY, Sangrar W, et al.: 1994. Binding of recombinant apolipoprotein(a) to extracellular matrix proteins. Arterioscler Thromb 14:1792-1798.
36. Wight TN: 1996. The vascular extracellular matrix. In: Fuster V, Ross R, Topol E, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia, Lippincott-Raven, p: 421.
37. Williams KJ, Tabas I: 1995. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 15:551-561.